(Q35863015)

10 August 2017

1 reference

title

Azithromycin and dentistry - a useful agent? (English)

1 reference

10 August 2017

0 references

Addy LD

1 reference

10 August 2017

Martin MV

series ordinal

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

10 August 2017

published in

British Dental Journal

1 reference

10 August 2017

volume

197

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

141-3; discussion 138

1 reference

Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Prevention of bacterial endocarditis. Recommendations by the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Erythromycin: a microbial and clinical perspective after 30 years of clinical use (2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

The 25.2 MDa tetracycline-resistance plasmid is not derived from the 24.5 MDa conjugative plasmid of Neisseria gonorrhoeae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Dental anxiety and the absorption of orally administered erythromycin stearate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Intracellular accumulation of azithromycin by cultured human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Induction of beta-lactamase and methicillin resistance in unusual strains of methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Selection of dose regimens of azithromycin .

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Interaction between piroxicam and azithromycin during distribution to human periodontal tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Clinical toleration and safety of azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Resistance in oral streptococci after repeated three-dose erythromycin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

"Conjugal" transfer of plasmid DNA among oral streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

Azithromycin--review of key chemical, pharmacokinetic and microbiological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

Comparison of the acid stability of azithromycin and erythromycin A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

High dose oral erythromycin for preventing endocarditis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

The pharmacokinetics of azithromycin in human serum and tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

Azithromycin in the treatment of periodontal disease. Effect on microbial flora

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

Periodontal tissue disposition of azithromycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

Clinical safety and tolerance of azithromycin in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BDJ.4811530

7 January 2021

Identifiers

DOI

10.1038/SJ.BDJ.4811530

1 reference

10 August 2017

1 reference